Você está em: Start > Publications > View > West Nile Virus Neuroinvasive Disease: why it should be considered in the Iberian Peninsula
Map of Premises
West Nile Virus Neuroinvasive Disease: why it should be considered in the Iberian Peninsula
Title
West Nile Virus Neuroinvasive Disease: why it should be considered in the Iberian Peninsula
Type
Thesis
Year
2019-05-23
Authors
João Carlos Silva Matos
(Author)
FMUP
View Personal Page
You do not have permissions to view the institutional email.
Search for Participant Publications
Without AUTHENTICUS
Without ORCID
Thesis
Master's Degree
Dissertation
Scientific classification
FOS:
Medical and Health sciences > Clinical medicine
Associated Institutions
Other information
Language:
English
License type:
Documents
| File name | Description | Size |
|---|---|---|
| Tese | West Nile Virus Neuroinvasive Disease: why it should be considered in the Iberian Peninsula | 1439.50 KB |
Related Publications
Of the same scientific areas
“Troponina e Peptídeo Natriurético tipo B no prognóstico da Estenose Valvular Aórtica” (2018)
Thesis
Pedro Francisco Santos Madeira Guimarães Ramos
Thesis
Pedro Francisco Santos Madeira Guimarães Ramos
“EXIT procedure from a maternal perspective: is it safe? – a systematic review”. (2022)
Thesis
Bárbara Andreia da Silva Nunes Pereira
Thesis
Bárbara Andreia da Silva Nunes Pereira
Xerostomia no internamento de Medicina da Unidade Local de Saúde (ULSSA) - Prevalência e Tratamento (2024)
Thesis
Margarida Figueiredo Furtado Brandão de Menezes
Thesis
Margarida Figueiredo Furtado Brandão de Menezes
Withdrawal of Antidementia Drugs in Advanced Dementia (WADAD): a randomized clinical trial and cost-utility analysis (2022)
Thesis
Rute Filipa Crespo Gonçalves
Thesis
Rute Filipa Crespo Gonçalves
Copyright 1996-2024 © Faculdade de Arquitectura da Universidade do Porto
I Terms and Conditions
I Acessibility
I Index A-Z
I Guest Book
Page created on: 2024-07-26 at 18:33:41 | Acceptable Use Policy | Data Protection Policy | Complaint Portal
Page created on: 2024-07-26 at 18:33:41 | Acceptable Use Policy | Data Protection Policy | Complaint Portal